Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adams Respiratory Therapeutics
Adams Respiratory Therapeutics
(ARXT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Erdosteine
healthy volunteers/patients
,
infections
,
acquired immunodeficiency syndrome
,
communicable diseases
,
hiv infections
,
chronic bronchitis
,
bronchitis
,
fatty liver
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
hiv-1
Lotamilast
healthy volunteers/patients
,
agnosia
,
pain
,
bone fractures
,
acute pain
Remetinostat
anesthesia
,
cystoscopes
,
anesthesia recovery period
,
aortic valve stenosis
,
renal insufficiency
,
delayed emergence from anesthesia
,
vaginal diseases
,
calculi
,
ureteral obstruction
,
obesity
,
arthritis
,
sleep wake disorders
,
coronary artery bypass
,
delirium
,
dementia
,
morbidity
,
amnesia
,
cognition disorders
,
lung neoplasms
Tiratricol
respiratory tract infections
,
common cold
Usistapide
myelodysplastic syndromes
,
recurrence
,
myeloid leukemia acute
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use